News & Events :: CNS Pharmaceuticals, Inc. (CNSP)

Recent News View All News

CNS Pharmaceuticals Continues to Execute on Corporate, Clinical and Regulatory Strategies to Drive Berubicin Towards Commercialization for the Treatment of GBM

Jul 1, 2021 9:05am EDT

FDA Grants Fast Track Designation to CNS Pharmaceuticals for Berubicin for the Treatment of Recurrent Glioblastoma Multiforme

Jun 29, 2021 8:35am EDT

Recent Events View IR Calendar

Annual Meeting of Stockholders

Jun 28, 2021 • 8:00 am MDT

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings